xIPOmeter
EQRx
EQRx aims to deliver medicines at lower prices by partnering with healthcare system actors and using cutting-edge technologies. The firm is located in Cambridge, MA.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
News related to EQRx147
EQRxDEE Inc. CEO, Sandra Daley teams up with Botswana Investment ...
ORLANDO, FL., Dec. 17, 2021 (GLOBE NEWSWIRE) -- With her ongoing success as an entrepreneur and business owner, CEO Sandra Daley is now working towards ...
https://finance.yahoo.com/finance/news/dee-inc-ceo-sandra-daley-175400624.htmlEQRxStitch Fix Announces New Employee Inducement Grant
The stock options vest over three years, with one sixth of the shares vesting on the six-month anniversary of Ms. Aiello's grant date and the remainder ...
https://ca.finance.yahoo.com/news/stitch-fix-announces-employee-inducement-230100007.htmlEQRxStreetInsider.com
EQRx Debuts as Publicly Traded Company to Develop and Deliver Innovative Medicines at Radically Lower Prices...
https://www.streetinsider.com/news_quotes.php?id=19367629EQRxRLAY211217C00045000 (RLAY211217C00045000) Prezzo Titoli ...
Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent...
https://it.finance.yahoo.com/quote/RLAY211217C00045000?p=RLAY211217C00045000EQRx(CMLT) - CM Life Sciences III Merger Partner EQRx Debuts On ...
Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You'll have what you need to act ...
https://www.benzinga.com/news/21/12/24676155/cm-life-sciences-iii-merger-partner-eqrx-debuts-on-nasdaq
Show more (142)Investors5
Andreessen Horowitz
GV
Casdin Capital
ARCH Venture Partners
Section 32